Kaplonek P, Cizmeci D, Kwatra G, Izu A, Lee J, Bertera H, et al. ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19. Nat Immunol. 2023;24:1161-1172 pubmed publisher

Bartsch Y, Cizmeci D, Kang J, Gao H, Shi W, Chandrashekar A, et al. Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions. iScience. 2023;26:106582 pubmed publisher

Adams L, Leist S, Dinnon K, West A, Gully K, Anderson E, et al. Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination. Cell Rep. 2023;42:112326 pubmed publisher

Roy V, Jung W, Linde C, Coates E, Ledgerwood J, Costner P, et al. Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination. NPJ Vaccines. 2023;8:39 pubmed publisher

Boudreau C, Burke J, Roederer A, Gorman M, Mundle S, Lingwood D, et al. Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination. Cell Rep Med. 2023;4:100975 pubmed publisher

Loos C, Coccia M, Didierlaurent A, Essaghir A, Fallon J, Lauffenburger D, et al. Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design. NPJ Vaccines. 2023;8:34 pubmed publisher

Rohwedder I, Wackerbarth L, Heinig K, Ballweg A, Altst xe4 tter J, Ripphahn M, et al. A20 and the noncanonical NF-κB pathway are key regulators of neutrophil recruitment during fetal ontogeny. JCI Insight. 2023;8: pubmed publisher

Herman J, Wang C, Burke J, Zur Y, Compere H, Kang J, et al. Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy. Cell Rep Med. 2022;3:100811 pubmed publisher

Bates T, Lu P, Kang Y, Schoen D, Thornton M, McBride S, et al. BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age. Cell Rep. 2022;41:111544 pubmed publisher

LaSalle T, Gonye A, Freeman S, Kaplonek P, Gushterova I, Kays K, et al. Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients. Cell Rep Med. 2022;3:100779 pubmed publisher

Dolatshahi S, Butler A, Pou C, Henckel E, Bernhardsson A, Gustafsson A, et al. Selective transfer of maternal antibodies in preterm and fullterm children. Sci Rep. 2022;12:14937 pubmed publisher

Bernshtein B, Ndungo E, Cizmeci D, Xu P, Kov xe1 x10d P, Kelly M, et al. Systems approach to define humoral correlates of immunity to Shigella. Cell Rep. 2022;40:111216 pubmed publisher

Davies L, Cizmeci D, Guo W, Luedemann C, Alexander Parrish R, Grant L, et al. Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses. Sci Transl Med. 2022;14:eabm4065 pubmed publisher

Bartsch Y, St Denis K, Kaplonek P, Kang J, Lam E, Burns M, et al. SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children. Sci Transl Med. 2022;14:eabn9237 pubmed publisher

Malherbe D, Domi A, Hauser M, Atyeo C, Fischinger S, Hyde M, et al. A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection. NPJ Vaccines. 2022;7:83 pubmed publisher

Atyeo C, Shook L, Brigida S, De Guzman R, Demidkin S, Muir C, et al. Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms. Nat Commun. 2022;13:3571 pubmed publisher

House R, Broge T, Suscovich T, Snow D, Tomic M, Nonet G, et al. Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics. PLoS ONE. 2022;17:e0267796 pubmed publisher

Spatola M, Loos C, Cizmeci D, Webb N, Gorman M, Rossignol E, et al. Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection. J Infect Dis. 2022;226:738-750 pubmed publisher

Zelter T, Strahilevitz J, Simantov K, Yajuk O, Adams Y, Ramstedt Jensen A, et al. Neutrophils impose strong immune pressure against PfEMP1 variants implicated in cerebral malaria. EMBO Rep. 2022;23:e53641 pubmed publisher

Schloss M, Hulsmans M, Rohde D, Lee I, Severe N, Foy B, et al. B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis. Nat Immunol. 2022;23:605-618 pubmed publisher

Kaplonek P, Cizmeci D, Fischinger S, Collier A, SUSCOVICH T, Linde C, et al. mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions. Sci Transl Med. 2022;14:eabm2311 pubmed publisher

Boudreau C, Burke J, Shuey K, Wolf C, Katz J, Tielsch J, et al. Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial. Cell Rep. 2022;38:110337 pubmed publisher

Kaplonek P, Fischinger S, Cizmeci D, Bartsch Y, Kang J, Burke J, et al. mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern. Immunity. 2022;55:355-365.e4 pubmed publisher

Das J, Fallon J, Yu T, Michell A, Suscovich T, Linde C, et al. Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies. Med. 2021;2:1269-1286.e9 pubmed publisher

Herman J, Wang C, Loos C, Yoon H, Rivera J, Eugenia Dieterle M, et al. Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response. Nat Commun. 2021;12:6853 pubmed publisher

Chen R, Gorman M, Zhu D, Carre xf1 o J, Yuan D, Vanblargan L, et al. Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors. Med. 2021;2:1327-1341.e4 pubmed publisher

Pullen K, Atyeo C, Collier A, Gray K, Belfort M, Lauffenburger D, et al. Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection. Cell Rep. 2021;37:109959 pubmed publisher

Krampert L, Bauer K, Ebner S, Neubert P, Ossner T, Weigert A, et al. High Na+ Environments Impair Phagocyte Oxidase-Dependent Antibacterial Activity of Neutrophils. Front Immunol. 2021;12:712948 pubmed publisher

Gorman M, Patel N, Guebre Xabier M, Zhu A, Atyeo C, Pullen K, et al. Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination. Cell Rep Med. 2021;2:100405 pubmed publisher

Williamson L, Reeder K, Bailey K, Tran M, Roy V, Fouch M, et al. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell. 2021;184:4430-4446.e22 pubmed publisher

Grace P, Dolatshahi S, Lu L, Cain A, Palmieri F, Petrone L, et al. Antibody Subclass and Glycosylation Shift Following Effective TB Treatment. Front Immunol. 2021;12:679973 pubmed publisher

Minassian A, Silk S, Barrett J, Nielsen C, Miura K, Diouf A, et al. Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination. Med (N Y). 2021;2:701-719.e19 pubmed publisher

Jundi B, Lee D, Jeon H, Duvall M, Nijmeh J, Abdulnour R, et al. Inflammation resolution circuits are uncoupled in acute sepsis and correlate with clinical severity. JCI Insight. 2021;6: pubmed publisher

Rossignol E, Dugast A, Compere H, Cottrell C, Copps J, Lin S, et al. Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells. Cell Rep. 2021;35:109167 pubmed publisher

Gunn B, Lu R, Slein M, Ilinykh P, Huang K, Atyeo C, et al. A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus. Immunity. 2021;54:815-828.e5 pubmed publisher

Cadena A, Ventura J, Abbink P, Borducchi E, Tuyishime H, Mercado N, et al. Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques. Nat Commun. 2021;12:1474 pubmed publisher

Bartsch Y, Fischinger S, Siddiqui S, Chen Z, Yu J, Gebre M, et al. Discrete SARS-CoV-2 antibody titers track with functional humoral stability. Nat Commun. 2021;12:1018 pubmed publisher

Atyeo C, Pullen K, Bordt E, Fischinger S, Burke J, Michell A, et al. Compromised SARS-CoV-2-specific placental antibody transfer. Cell. 2021;184:628-642.e10 pubmed publisher

Atyeo C, Slein M, Fischinger S, Burke J, Sch xe4 fer A, Leist S, et al. Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022. JCI Insight. 2021;6: pubmed publisher

Barrett J, Belij Rammerstorfer S, Dold C, Ewer K, Folegatti P, Gilbride C, et al. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Nat Med. 2021;27:279-288 pubmed publisher

Offersen R, Yu W, Scully E, Julg B, Euler Z, Sadanand S, et al. HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound. Cell Rep. 2020;33:108502 pubmed publisher

Alter G, Yu W, Chandrashekar A, Borducchi E, Ghneim K, Sharma A, et al. Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques. Cell. 2020;183:185-196.e14 pubmed publisher

Om K, Paquin Proulx D, Montero M, Peachman K, Shen X, Wieczorek L, et al. Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge. PLoS Pathog. 2020;16:e1008764 pubmed publisher

HUBBARD J, Pyzik M, Rath T, Kozicky L, Sand K, Gandhi A, et al. FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity. J Exp Med. 2020;217: pubmed publisher

Kwok I, Becht E, Xia Y, Ng M, Teh Y, Tan L, et al. Combinatorial Single-Cell Analyses of Granulocyte-Monocyte Progenitor Heterogeneity Reveals an Early Uni-potent Neutrophil Progenitor. Immunity. 2020;: pubmed publisher

Gilchuk P, Murin C, Milligan J, Cross R, Mire C, Ilinykh P, et al. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization. Immunity. 2020;52:388-403.e12 pubmed publisher

Boudreau C, Yu W, Suscovich T, Talbot H, Edwards K, Alter G. Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination. J Clin Invest. 2020;130:662-672 pubmed publisher

Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher

Jennewein M, Goldfarb I, Dolatshahi S, Cosgrove C, Noelette F, Krykbaeva M, et al. Fc Glycan-Mediated Regulation of Placental Antibody Transfer. Cell. 2019;: pubmed publisher

Spolski R, West E, Li P, Veenbergen S, Yung S, Kazemian M, et al. IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus. elife. 2019;8: pubmed publisher

Bornholdt Z, Herbert A, Mire C, He S, Cross R, Wec A, et al. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates. Cell Host Microbe. 2019;25:49-58.e5 pubmed publisher

Ilinykh P, Santos R, Gunn B, Kuzmina N, Shen X, Huang K, et al. Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. PLoS Pathog. 2018;14:e1007204 pubmed publisher

Gunn B, Yu W, Karim M, Brannan J, Herbert A, Wec A, et al. A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. Cell Host Microbe. 2018;24:221-233.e5 pubmed publisher

King L, Fusco M, Flyak A, Ilinykh P, Huang K, Gunn B, et al. The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. Cell Host Microbe. 2018;23:101-109.e4 pubmed publisher

Alcántara Hernández M, Leylek R, Wagar L, Engleman E, Keler T, Marinkovich M, et al. High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization. Immunity. 2017;47:1037-1050.e6 pubmed publisher

Lu L, Chung A, Rosebrock T, Ghebremichael M, Yu W, Grace P, et al. A Functional Role for Antibodies in Tuberculosis. Cell. 2016;167:433-443.e14 pubmed publisher